{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:17:13Z","timestamp":1793330233162,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006188","name":"Einstein Stiftung Berlin","doi-asserted-by":"publisher","award":["EPP-BUA-2022-697"],"award-info":[{"award-number":["EPP-BUA-2022-697"]}],"id":[{"id":"10.13039\/501100006188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Respiratory syncytial virus (RSV) causes over 100,000 annual deaths, predominantly in low- and middle-income countries, yet immunological correlates of protection remain poorly defined in high-burden settings. This study aims to identify immunological correlates of protection against RSV infection, and to compare the relative contribution of systemic and mucosal antibody responses. We use data from an intensively sampled prospective household cohort study in The Gambia, following 342 participants over 12 months with weekly PCR testing and longitudinal serum and nasal sampling. Using a Bayesian hierarchical framework jointly modelling antibody kinetics, household transmission dynamics, and imperfect PCR ascertainment, we characterise humoral immunity to RSV-A antigens across systemic and mucosal compartments. Mucosal IgA to the pre-fusion F (pre-F) protein is the strongest predictor of protection against infection (AUC\u2009=\u20090.72), outperforming serum anti-Pre-F IgG (AUC\u2009=\u20090.66). Serum and mucosal responses are largely compartment-independent (r\u2009=\u20090.02\u20130.28), with a combined serum and mucosal anti-Pre-F model outperforming either alone, and both biomarkers correlating with RSV-A neutralising titres. These findings have direct implications for designing RSV infection-preventing vaccine strategies.<\/jats:p>","DOI":"10.1038\/s41467-026-77315-4","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:04:17Z","timestamp":1787745857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mucosal IgA to pre-fusion F protein predicts protection from RSV infection in a high burden setting"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5585-8974","authenticated-orcid":false,"given":"David","family":"Hodgson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Jarju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gatcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Dowgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys D.","family":"Wenlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-2592","authenticated-orcid":false,"given":"Benjamin B.","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madikoi","family":"Danso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Grouneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya Jankey","family":"Jagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-4709","authenticated-orcid":false,"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2074-6171","authenticated-orcid":false,"given":"Mary Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Otter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Flasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kucharski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6498-9212","authenticated-orcid":false,"given":"Thushan I.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"77315_CR1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 399, 2047\u20132064 (2022).","journal-title":"Lancet"},{"key":"77315_CR2","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/S2214-109X(21)00518-0","volume":"10","author":"CJ Gill","year":"2022","unstructured":"Gill, C. J. et al. Infant deaths from respiratory syncytial virus in Lusaka, Zambia from the ZPRIME study: a 3-year, systematic, post-mortem surveillance project. Lancet Glob. Health 10, e269\u2013e277 (2022).","journal-title":"Lancet Glob. Health"},{"key":"77315_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2209604","volume":"388","author":"A Papi","year":"2023","unstructured":"Papi, A. et al. Respiratory syncytial virus prefusion f protein vaccine in older adults. N. Engl. J. Med. 388, 595\u2013608 (2023).","journal-title":"N. Engl. J. Med."},{"key":"77315_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","volume":"388","author":"EE Walsh","year":"2023","unstructured":"Walsh, E. E. et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N. Engl. J. Med. 388, 1465\u20131477 (2023).","journal-title":"N. Engl. J. Med."},{"key":"77315_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","volume":"386","author":"LL Hammitt","year":"2022","unstructured":"Hammitt, L. L. et al. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N. Engl. J. Med. 386, 837\u2013846 (2022).","journal-title":"N. Engl. J. Med."},{"key":"77315_CR6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","volume":"388","author":"B Kampmann","year":"2023","unstructured":"Kampmann, B. et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N. Engl. J. Med. 388, 1451\u20131464 (2023).","journal-title":"N. Engl. J. Med."},{"key":"77315_CR7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1056\/NEJMoa2502984","volume":"393","author":"HJ Zar","year":"2025","unstructured":"Zar, H. J. et al. Clesrovimab for Prevention of RSV Disease in Healthy Infants. N. Engl. J. Med. 393, 1292\u20131303 (2025).","journal-title":"N. Engl. J. Med."},{"key":"77315_CR8","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","volume":"389","author":"E Wilson","year":"2023","unstructured":"Wilson, E. et al. Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults. N. Engl. J. Med. 389, 2233\u20132244 (2023).","journal-title":"N. Engl. J. Med."},{"key":"77315_CR9","doi-asserted-by":"publisher","unstructured":"Moline, H. L. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus\u2013Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season \u2014 New Vaccine Surveillance Network, October 2023\u2013February 2024. MMWR Morb Mortal Wkly Rep 73, https:\/\/doi.org\/10.15585\/mmwr.mm7309a4 (2024).","DOI":"10.15585\/mmwr.mm7309a4"},{"key":"77315_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S2352-4642(25)00155-5","volume":"9","author":"TC Williams","year":"2025","unstructured":"Williams, T. C. et al. Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study.  Lancet Child Adolesc. Health 9, 655\u2013662 (2025).","journal-title":"Lancet Child Adolesc. Health"},{"key":"77315_CR11","doi-asserted-by":"publisher","unstructured":"Fry, S., Terebuh, P., Kaelber, D. C., Xu, R. & Davis, P. Effectiveness and Safety of Respiratory Syncytial Virus Vaccine for US Adults Aged 60 Years or Older. JAMA network open 8, https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.8322 (2025).","DOI":"10.1001\/jamanetworkopen.2025.8322"},{"key":"77315_CR12","unstructured":"CDC. RSV Vaccine Guidance for Adults. Respiratory Syncytial Virus Infection (RSV) https:\/\/www.cdc.gov\/rsv\/hcp\/vaccine-clinical-guidance\/adults.html (2025)."},{"key":"77315_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/1744666X.2025.2494658","volume":"21","author":"A Chaumont","year":"2025","unstructured":"Chaumont, A. et al. Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review. Expert Rev. Clin. Immunol. 21, 745\u2013760 (2025).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"77315_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0140-6736(24)01716-1","volume":"404","author":"NI Mazur","year":"2024","unstructured":"Mazur, N. I., Caballero, M. T. & Nunes, M. C. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.  Lancet 404, 1143\u20131156 (2024).","journal-title":"Lancet"},{"key":"77315_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/rmv.1771","volume":"24","author":"JW Tang","year":"2014","unstructured":"Tang, J. W. & Loh, T. P. Correlations between climate factors and incidence\u2014a contributor to RSV seasonality. Rev. Med. Virol. 24, 15\u201334 (2014).","journal-title":"Rev. Med. Virol."},{"key":"77315_CR16","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1093\/infdis\/jiaf101","volume":"231","author":"F Reicherz","year":"2025","unstructured":"Reicherz, F. et al. Recovery of antibody immunity after a resurgence of respiratory syncytial virus infections. J. Infect. Dis. 231, e840\u2013e845 (2025).","journal-title":"J. Infect. Dis."},{"key":"77315_CR17","doi-asserted-by":"publisher","unstructured":"Asseri, A. A. Respiratory syncytial virus: a narrative review of updates and recent advances in epidemiology, pathogenesis, diagnosis, management and prevention. J. Clin. Med. 14, https:\/\/doi.org\/10.3390\/jcm14113880 (2025).","DOI":"10.3390\/jcm14113880"},{"key":"77315_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/CVI.00590-15","volume":"23","author":"M Vissers","year":"2016","unstructured":"Vissers, M., Ahout, I. M. L., de Jonge, M. I. & Ferwerda, G. Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels. Clin. Vaccin. Immunol. 23, 243\u2013245 (2016).","journal-title":"Clin. Vaccin. Immunol."},{"key":"77315_CR19","doi-asserted-by":"publisher","first-page":"1448578","DOI":"10.3389\/fimmu.2024.1448578","volume":"15","author":"D \u00d6ner","year":"2024","unstructured":"\u00d6ner, D. et al. Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe. Front Immunol. 15, 1448578 (2024).","journal-title":"Front Immunol."},{"key":"77315_CR20","doi-asserted-by":"publisher","first-page":"2384192","DOI":"10.1080\/21645515.2024.2384192","volume":"20","author":"M Maltseva","year":"2024","unstructured":"Maltseva, M., Keeshan, A., Cooper, C. & Langlois, M.-A. Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses. Hum. Vaccines Immunotherapeutics 20, 2384192 (2024).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"77315_CR21","doi-asserted-by":"publisher","unstructured":"Jarju, S. et al. Incidence, Shedding and Transmission Amongst Common Respiratory Viruses: Data from a Prospective, Longitudinal, Household Cohort Study in the Gambia. SSRN Scholarly Paper at https:\/\/doi.org\/10.2139\/ssrn.5516505 (2025).","DOI":"10.2139\/ssrn.5516505"},{"key":"77315_CR22","doi-asserted-by":"publisher","unstructured":"Hodgson, D. et al. Impact of SARS-CoV-2 exposure history on antibody kinetics and correlates of protection in The Gambia. 2026.01.02.26343369 Preprint at https:\/\/doi.org\/10.64898\/2026.01.02.26343369 (2026).","DOI":"10.64898\/2026.01.02.26343369"},{"key":"77315_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48098-3","volume":"15","author":"S Jarju","year":"2024","unstructured":"Jarju, S. et al. High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia. Nat. Commun. 15, 3814 (2024).","journal-title":"Nat. Commun."},{"key":"77315_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s43856-025-00902-x","volume":"5","author":"YJ Jagne","year":"2025","unstructured":"Jagne, Y. J. et al. Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa. Commun. Med. 5, 178 (2025).","journal-title":"Commun. Med"},{"key":"77315_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44275-y","volume":"15","author":"C Cohen","year":"2024","unstructured":"Cohen, C. et al. Incidence and transmission of respiratory syncytial virus in urban and rural South Africa, 2017-2018. Nat. Commun. 15, 116 (2024).","journal-title":"Nat. Commun."},{"key":"77315_CR26","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/cid\/ciy313","volume":"67","author":"PK Munywoki","year":"2018","unstructured":"Munywoki, P. K. et al. Continuous invasion by respiratory viruses observed in rural households during a respiratory syncytial virus seasonal outbreak in coastal kenya. Clin. Infect. Dis. 67, 1559\u20131567 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"77315_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/cid\/ciae491","volume":"80","author":"EB White","year":"2025","unstructured":"White, E. B. et al. Influenza vaccine effectiveness against illness and asymptomatic infection in 2022\u20132023: a prospective cohort study. Clin. Infect. Dis. 80, 893\u2013900 (2025).","journal-title":"Clin. Infect. Dis."},{"key":"77315_CR28","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3201\/eid2407.171928","volume":"24","author":"BF Arnold","year":"2018","unstructured":"Arnold, B. F., Scobie, H. M., Priest, J. W. & Lammie, P. J. Integrated Serologic Surveillance of Population Immunity and Disease Transmission. Emerg. Infect. Dis. 24, 1188\u20131194 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"77315_CR29","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar, J. N. Receiver operating characteristic curve in diagnostic test assessment. J. Thorac. Oncol. 5, 1315\u20131316 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"77315_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63434-x","volume":"16","author":"C Frivold","year":"2025","unstructured":"Frivold, C. et al. Correlates of risk of respiratory syncytial virus disease: a prospective cohort study. Nat. Commun. 16, 8490 (2025).","journal-title":"Nat. Commun."},{"key":"77315_CR31","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.chom.2021.10.009","volume":"29","author":"DR McIlwain","year":"2021","unstructured":"McIlwain, D. R. et al. Human influenza virus challenge identifies cellular correlates of protection for oral vaccination. Cell Host Microbe 29, 1828\u20131837.e5 (2021).","journal-title":"Cell Host Microbe"},{"key":"77315_CR32","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","volume":"191","author":"MS Habibi","year":"2015","unstructured":"Habibi, M. S. et al. Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 191, 1040\u20131049 (2015).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"77315_CR33","doi-asserted-by":"publisher","unstructured":"\u00d6ner, D. et al. Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe. Front. Immunol. 15, https:\/\/doi.org\/10.3389\/fimmu.2024.1448578 (2024).","DOI":"10.3389\/fimmu.2024.1448578"},{"key":"77315_CR34","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/infdis\/jiv281","volume":"212","author":"B Bagga","year":"2015","unstructured":"Bagga, B. et al. Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults. J. Infect. Dis. 212, 1719\u20131725 (2015).","journal-title":"J. Infect. Dis."},{"key":"77315_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/aje\/kwz227","volume":"189","author":"WW Lim","year":"2020","unstructured":"Lim, W. W., Leung, N. H. L., Sullivan, S. G., Tchetgen Tchetgen, E. J. & Cowling, B. J. Distinguishing causation from correlation in the use of correlates of protection to evaluate and develop influenza vaccines. Am. J. Epidemiol. 189, 185\u2013192 (2020).","journal-title":"Am. J. Epidemiol."},{"key":"77315_CR36","doi-asserted-by":"publisher","first-page":"10972","DOI":"10.1128\/JVI.76.21.10972-10979.2002","volume":"76","author":"H Yan","year":"2002","unstructured":"Yan, H., Lamm, M. E., Bj\u00f6rling, E. & Huang, Y. T. Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. J. Virol. 76, 10972\u201310979 (2002).","journal-title":"J. Virol."},{"key":"77315_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fimmu.2013.00185","volume":"4","author":"B Corth\u00e9sy","year":"2013","unstructured":"Corth\u00e9sy, B. Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces. Front Immunol. 4, 185 (2013).","journal-title":"Front Immunol."},{"key":"77315_CR38","first-page":"421","volume":"89","author":"LG Stensballe","year":"2000","unstructured":"Stensballe, L. G. et al. Duration of secretory IgM and IgA antibodies to respiratory syncytial virus in a community study in Guinea-Bissau. Acta Paediatr. 89, 421\u2013426 (2000).","journal-title":"Acta Paediatr."},{"key":"77315_CR39","unstructured":"Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice | Mucosal Immunology. https:\/\/www.nature.com\/articles\/mi201538."},{"key":"77315_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri1886","volume":"6","author":"A Radbruch","year":"2006","unstructured":"Radbruch, A. et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6, 741\u2013750 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"77315_CR41","doi-asserted-by":"publisher","unstructured":"Weisel, F. & Shlomchik, S. Memory B cells of mice and humans. Ann. Rev. Immunol. 35, https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055531 (2017).","DOI":"10.1146\/annurev-immunol-041015-055531"},{"key":"77315_CR42","doi-asserted-by":"crossref","unstructured":"Gd, V. & Mc, N. Germinal Centers. Annual review of immunology 40, (2022).","DOI":"10.1146\/annurev-immunol-120419-022408"},{"key":"77315_CR43","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/ni.3680","volume":"18","author":"D Angeletti","year":"2017","unstructured":"Angeletti, D. et al. Defining B cell immunodominance to viruses. Nat. Immunol. 18, 456\u2013463 (2017).","journal-title":"Nat. Immunol."},{"key":"77315_CR44","doi-asserted-by":"publisher","first-page":"15798","DOI":"10.1073\/pnas.1409171111","volume":"111","author":"SL Linderman","year":"2014","unstructured":"Linderman, S. L. et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013\u20132014 influenza season. Proc. Natl. Acad. Sci. 111, 15798\u201315803 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77315_CR45","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon, A. K., Hollander, G. A. & McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. R. Soc. B: Biol. Sci. 282, 20143085 (2015).","journal-title":"Proc. R. Soc. B: Biol. Sci."},{"key":"77315_CR46","first-page":"23","volume":"3","author":"J Reis","year":"2018","unstructured":"Reis, J. & Shaman, J. Simulation of four respiratory viruses and inference of epidemiological parameters. Infect. Dis. Model. 3, 23\u201334 (2018).","journal-title":"Infect. Dis. Model."},{"key":"77315_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01186-x","volume":"10","author":"E Jang","year":"2025","unstructured":"Jang, E., Lee, S., Han, J. & Chang, J. Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2. npj Vaccines 10, 139 (2025).","journal-title":"npj Vaccines"},{"key":"77315_CR48","doi-asserted-by":"crossref","unstructured":"Lei, H. et al. Intranasal Inoculation of Cationic Crosslinked Carbon Dots-Adjuvanted Respiratory Syncytial Virus F Subunit Vaccine Elicits Mucosal and Systemic Humoral and Cellular Immunity. MedComm (2020) 6, e70146 (2025).","DOI":"10.1002\/mco2.70146"},{"key":"77315_CR49","doi-asserted-by":"publisher","first-page":"e1146","DOI":"10.1093\/infdis\/jiaf149","volume":"231","author":"EE Walsh","year":"2025","unstructured":"Walsh, E. E., Peasley, M., Branche, A. R. & Falsey, A. R. Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection. J. Infect. Dis. 231, e1146\u2013e1150 (2025).","journal-title":"J. Infect. Dis."},{"key":"77315_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920256","volume":"13","author":"C Maier","year":"2022","unstructured":"Maier, C. et al. Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity. Front Immunol. 13, 920256 (2022).","journal-title":"Front Immunol."},{"key":"77315_CR51","doi-asserted-by":"publisher","first-page":"iqaf007","DOI":"10.1093\/oxfimm\/iqaf007","volume":"6","author":"D Sinha","year":"2025","unstructured":"Sinha, D., Gopalakrishna, P. K., Paul, S. & Longet, S. A user\u2019s guide to designing efficient and safe mucosal vaccines: Challenges & potentials. Oxf. Open Immunol. 6, iqaf007 (2025).","journal-title":"Oxf. Open Immunol."},{"key":"77315_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra, M. R. & Kozlowski, P. A. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6, 148\u2013158 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"77315_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/14760584.2024.2326094","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines. Expert Rev. Vaccines 23, 362\u2013370 (2024).","journal-title":"Expert Rev. Vaccines"},{"key":"77315_CR54","doi-asserted-by":"publisher","first-page":"102324","DOI":"10.1016\/j.eclinm.2023.102324","volume":"66","author":"NI Mazur","year":"2023","unstructured":"Mazur, N. I. et al. Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1\/2b randomized placebo-controlled trial. eClinicalMedicine 66, 102324 (2023).","journal-title":"eClinicalMedicine"},{"key":"77315_CR55","unstructured":"Transmission of Respiratory Viruses in Households in The Gambia: a Longitudinal Cohort Study (TransVIR) (TransVIR). ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05952336 (2023)."},{"key":"77315_CR56","doi-asserted-by":"publisher","first-page":"e0266412","DOI":"10.1371\/journal.pone.0266412","volume":"17","author":"L Broadbent","year":"2022","unstructured":"Broadbent, L. et al. An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells. PLOS ONE 17, e0266412 (2022).","journal-title":"PLOS ONE"},{"key":"77315_CR57","doi-asserted-by":"publisher","unstructured":"Jorquera, P. A. & Tripp, R. A. Quantification of RSV Infectious Particles by Plaque Assay and Immunostaining Assay. in Human Respiratory Syncytial Virus: Methods and Protocols (eds Tripp, R. A. & Jorquera, P. A.) 33\u201340 (Springer, New York, NY, 2016) https:\/\/doi.org\/10.1007\/978-1-4939-3687-8_3.","DOI":"10.1007\/978-1-4939-3687-8_3"},{"key":"77315_CR58","unstructured":"Three-dose vaccination elicits neutralising antibodies against omicron - The Lancet https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(22)00092-7\/fulltext."},{"key":"77315_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.epidem.2016.04.001","volume":"16","author":"PFM Teunis","year":"2016","unstructured":"Teunis, P. F. M., van Eijkeren, J. C. H., de Graaf, W. F., Marinovi\u0107, A. B. & Kretzschmar, M. E. E. Linking the seroresponse to infection to within-host heterogeneity in antibody production. Epidemics 16, 33\u201339 (2016).","journal-title":"Epidemics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77315-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:22:27Z","timestamp":1787746947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77315-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77315"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77315-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9056"}}